Per Kogner

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

Author Correction: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.

Author Correction: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.

Journal: Nature communications

Published: August 27, 2026

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

Journal: Drug delivery

Published: May 02, 2026

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers.

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers.

Journal: EJHaem

Published: December 12, 2025

HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.

HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 21, 2025

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 14, 2025

DNA methylation profiling for molecular classification of neuroblastoma.

DNA methylation profiling for molecular classification of neuroblastoma.

Journal: Clinical epigenetics

Published: March 05, 2025

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Journal: Cancer letters

Published: February 25, 2025

Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report.

Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report.

Journal: Frontiers in oncology

Published: January 31, 2025

Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growth.

Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growth.

Journal: Cell death & disease

Published: July 17, 2024

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Journal: Cancer research communications

Published: June 20, 2024

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.

Journal: Journal of translational medicine

Published: June 17, 2024

Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance.

Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance.

Journal: Genes, chromosomes & cancer

Published: June 03, 2024

Showing 1-12 of 120

Last Updated: 09/26/2026